Abstract
The toxicity of chemotherapy agents to the peripheral nervous system (PNS) often manifests itself as chemotherapy-induced peripheral neuropathy (CIPN). Given the role of brain-derived neurotrophic factors (BDNF) and oxidative stress in the pathophysiology of peripheral neuropathy in different neurological diseases, the present study examined the possible interaction between these factors in the pathomechanism of CIPN in acute lymphoblastic leukemia (ALL) children. Forty children (3–14 years old) with ALL entered this study. Patients with or without presentation of CIPN symptoms were assigned to experimental and control groups, respectively. Following blood sampling, the serum level of BDNF and oxidative stress indices (catalase activity (CAT), super oxide dismutase (SOD), malondialdehyde (MDA)) were evaluated using biochemical assessment by enzyme-linked immunosorbent assay (ELISA). Although our results showed that compared to the control group, there were a significant decrease in the serum level of BDNF and a significant increase in the serum level of SOD and MDA in the experimental group, no significant correlation was observed between BDNF and oxidative stress factors. In addition, the mean serum level of BDNF and oxidative stress factors did not show any significant difference between both genders in the experimental and control groups. Therefore, given the role of serum changes of BDNF and oxidative stress factors in the occurrence of CINP, the use of neurotrophic factors and antioxidants in the chemotherapy process should be taken into account in future studies.
Similar content being viewed by others
REFERENCES
Markman, M., Current Pain and Headache Reports, 2006, vol. 10, no. 4, pp. 275–278.
Gurney, J.G., Severson, R.K., Davis, S., and Robison, L.L., Cancer, 1995, vol. 75, no. 8, pp. 2186–2195.
Ocean, A.J., and Vahdat, L.T., Supportive Care in Cancer, 2004, vol. 12, no. 9, pp. 619–625.
Windebank, A.J., and Grisold, W., Journal of the Peripheral Nervous System, 2008, vol. 13, no. 1, pp. 27–46.
Casey, E., Jellife, A., LE QUESNE, P.M., and Millett, Y.L., Brain, 1973, vol. 96, no. 1, pp. 69–86.
Hiser, L., Herrington, B., and Lobert, S., Leukemia & Lymphoma, 2008, vol. 49, no. 8, pp. 1603–1609.
Betteridge, D.J., Metabolism, 2000, vol. 49, no. 2, pp. 3–8.
Mallet, M.-L., Hadjivassiliou, M., Sarrigiannis, P.G., and Zis, P., Journal of molecular neuroscience, 2020, vol. 70, no. 7, pp. 1009–1017.
Kober, K.M., Olshen, A., Conley, Y.P., Schumacher, M., Topp, K., Smoot, B., Mazor, M., Chesney, M., Hammer, M., and Paul, S.M., Molecular Pain, 2018, vol. 14, no., pp. 1744806918816462.
Monk, B.J., Kauderer, J.T., Moxley, K.M., Bonebrake, A.J., Dewdney, S.B., Secord, A.A., Ueland, F.R., Johnston, C.M., and Aghajanian, C., Gynecologic Oncology, 2018, vol. 151, no. 3, pp. 422–427.
Gilchrist, L.S., and Tanner, L., Supportive Care in Cancer, 2013, vol. 21, no. 3, pp. 847–856.
Wright, M.J., Galea, V., and Barr, R.D., Physical Therapy, 2005, vol. 85, no. 8, pp. 782–790.
Hartman, A., van den Bos, C., Stijnen, T., and Pieters, R., Cancer: Interdisciplinary International Journal of the American Cancer Society, 2006, vol. 106, no. 6, pp. 1395–1401.
Dick, J., Journal of Neurology, Neurosurgery & Psychiatry, 2003, vol. 74, no. 2, pp. 150–153.
Deitz, J.C., Kartin, D., and Kopp, K., Physical & Occupational Therapy in Pediatrics, 2007, vol. 27, no. 4, pp. 87–102.
Zhang, X.Y., Chen, D.-C., Tan, Y.-L., Tan, S.-p., Wang, Z.-R., Yang, F.-D., Okusaga, O.O., Zunta-Soares, G.B., and Soares, J.C., Psychoneuroendocrinology, 2015, vol. 51, no., pp. 201–208.
Cavaletti, G., Bogliun, G., Marzorati, L., Zincone, A., Piatti, M., Colombo, N., Franchi, D., La Presa, M., Lissoni, A., and Buda, A., Annals of Oncology, 2004, vol. 15, no. 9, pp. 1439–1442.
Andreassen, C., Jakobsen, J., Flyvbjerg, A., and Andersen, H., Brain, 2009, vol. 132, no. 10, pp. 2724–2733.
Azoulay, D., Giryes, S., Nasser, R., Sharon, R., and Horowitz, N.A., Journal of Clinical Neurology, 2019, vol. 15, no. 4, pp. 511–516.
Szudy-Szczyrek, A., Mlak, R., Bury-Kamińska, M., Mielnik, M., Podgajna, M., Kuśmierczuk, K., Mazurek, M., Homa-Mlak, I., Szczyrek, M., and Krawczyk, J., British Journal of Haematology, 2020, vol. 191, no. 1, pp. 77–89.
Azoulay, D., Leibovici, A., Sharoni, R., Shaoul, E., Gross, B., Braester, A., and Goldberg, H., Breast Cancer Research and Treatment, 2015, vol. 153, no. 3, pp. 703.
Aloe, L., Manni, L., Properzi, F., De Santis, S., and Fiore, M., Autonomic Neuroscience, 2000, vol. 86, no. 1–2, pp. 84–93.
Mannelli, L.D.C., Zanardelli, M., Failli, P., and Ghelardini, C., The Journal of Pain, 2012, vol. 13, no. 3, pp. 276–284.
Joseph, E.K., Chen, X., Bogen, O., and Levine, J.D., The Journal of Pain, 2008, vol. 9, no. 5, pp. 463–472.
Imai, S., Koyanagi, M., Azimi, Z., Nakazato, Y., Matsumoto, M., Ogihara, T., Yonezawa, A., Omura, T., Nakagawa, S., and Wakatsuki, S., Scientific Reports, 2017, vol. 7, no. 1, pp. 1–14.
Waseem, M., Kaushik, P., Tabassum, H., and Parvez, S., Current Drug Metabolism, 2018, vol. 19, no. 1, pp. 47–54.
Sharawy, N., Rashed, L., and Youakim, M.F., Experimental and Toxicologic Pathology, 2015, vol. 67, no. 4, pp. 315–322.
Funding
This article was extracted from Dr. Zeinab Roshandelpour’s thesis and was financially supported by the Research Affairs Deputy of Ahvaz Jundishapur University of Medical Sciences (IR.AJUMS.REC.1399.106).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that there are no conflicts of interest.
Ethical approval. After the testing procedure and consent forms were reviewed, approval was obtained from the Institutional Ethics Committee for Human Research (IR.AJUMS.REC.1399.106) and the project was conducted in accordance with the principles of the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences (AJUMS).
Informed consent. Informed consent was obtained from all individual participants included in the study.
Additional information
Corresponding author; address: Department of Physiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, PO Box: 6135715753, Iran, e-mail: samireh.ghafouri@gmail.com.
Rights and permissions
About this article
Cite this article
Arash Alqasi, Roshandelpour, Z., Kahyesh, R.S. et al. Chemotherapy-Induced Peripheral Neuropathy in Children Treated for Acute Lymphoblastic Leukemia: A Role for Oxidative Stress and Brain-Derived Neurotrophic Factor. Neurochem. J. 17, 502–508 (2023). https://doi.org/10.1134/S1819712423030029
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712423030029